Skip to content

Maravai LifeSciences

US · MRVI #3116 by market cap Listed 2020
7.43 -0.42 -5.35%
Live - 5344 symbols - heartbeat 359s ago · 2026-10-07 19:54
After-hours 7.44 +0.13%
Market cap
1.11B
P/B
5.41
EPS
-0.90
Reader sentiment Are you bullish or bearish on MRVI?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    UBS Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $2.5
    Market Newswire · 2025/3/22
  • Rating change
    Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6
    Market Newswire · 2026/5/8
  • Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
    Market Newswire · 2026/2/28
  • William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
    Market Newswire · 2026/8/7
  • Rating change
    Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $4
    Market Newswire · 2025/11/8
  • Rating change
    Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6
    Market Newswire · 2026/5/12
  • Rating change
    Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4
    Market Newswire · 2025/8/13
  • Rating change
    Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
    Market Newswire · 2026/5/11
  • Rating change
    Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $4.5
    Market Newswire · 2025/12/15
  • Rating change
    A Quick Look at Today's Ratings for Maravai LifeSciences(MRVI.US), With a Forecast Between $5 to $5
    Market Newswire · 2025/8/12
  • Rating change
    Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $5
    Market Newswire · 2025/3/25
  • Rating change
    RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $7
    Market Newswire · 2025/4/10
  • Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5
    Market Newswire · 2026/5/8
  • Rating change
    Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Maintains Target Price $5
    Market Newswire · 2025/5/22
  • TD Cowen Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $9
    Market Newswire · 2026/10/5
  • Rating change
    William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Announces Target Price $3.94
    Market Newswire · 2026/5/8
  • Rating change
    Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $5
    Market Newswire · 2025/8/13
  • Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $8
    Market Newswire · 2026/8/13
  • Rating change
    Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $5
    Market Newswire · 2025/3/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.